If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
146
|
67
|
32
|
5
|
2
|
252
|
Gene and significance breakdown #
Total genes and gene combinations: 99
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
GAA
|
13
|
8
|
2
|
0 |
0 |
23
|
PCCA
|
20
|
0 |
0 |
0 |
2
|
22
|
CYP21A2, LOC106780800
|
1
|
5
|
14
|
0 |
0 |
20
|
KCNQ1
|
16
|
0 |
0 |
0 |
0 |
16
|
BCKDHB
|
10
|
0 |
0 |
0 |
0 |
10
|
BCKDHA
|
8
|
0 |
0 |
0 |
0 |
8
|
COL1A1
|
3
|
5
|
0 |
0 |
0 |
8
|
FBP1
|
3
|
4
|
0 |
0 |
0 |
7
|
BTK
|
6
|
0 |
0 |
0 |
0 |
6
|
MMUT
|
6
|
0 |
0 |
0 |
0 |
6
|
PCCB
|
6
|
0 |
0 |
0 |
0 |
6
|
COL1A2
|
2
|
3
|
0 |
0 |
0 |
5
|
SLC26A2
|
3
|
2
|
0 |
0 |
0 |
5
|
COL2A1
|
0 |
4
|
0 |
0 |
0 |
4
|
ALDH7A1
|
0 |
2
|
0 |
0 |
0 |
2
|
CANT1
|
2
|
0 |
0 |
0 |
0 |
2
|
CFTR
|
1
|
1
|
0 |
0 |
0 |
2
|
DBT
|
2
|
0 |
0 |
0 |
0 |
2
|
DPAGT1, LOC126861360
|
0 |
2
|
0 |
0 |
0 |
2
|
FBN1
|
2
|
0 |
0 |
0 |
0 |
2
|
HGD
|
1
|
0 |
1
|
0 |
0 |
2
|
IFT81
|
1
|
1
|
0 |
0 |
0 |
2
|
KCNJ1
|
2
|
0 |
0 |
0 |
0 |
2
|
LSS
|
0 |
0 |
2
|
0 |
0 |
2
|
MMAA
|
2
|
0 |
0 |
0 |
0 |
2
|
MMAB
|
2
|
0 |
0 |
0 |
0 |
2
|
NPC1
|
0 |
1
|
1
|
0 |
0 |
2
|
PDHX
|
1
|
0 |
1
|
0 |
0 |
2
|
POLG, POLGARF
|
0 |
2
|
0 |
0 |
0 |
2
|
PROM1
|
1
|
1
|
0 |
0 |
0 |
2
|
SCN1A
|
2
|
0 |
0 |
0 |
0 |
2
|
SCN5A
|
2
|
0 |
0 |
0 |
0 |
2
|
TRIP11
|
1
|
1
|
0 |
0 |
0 |
2
|
TUBGCP6
|
0 |
2
|
0 |
0 |
0 |
2
|
WDR19
|
0 |
1
|
1
|
0 |
0 |
2
|
ABCA3
|
0 |
1
|
0 |
0 |
0 |
1
|
AGO2, LOC126860544
|
0 |
0 |
0 |
1
|
0 |
1
|
AKR1D1
|
0 |
0 |
1
|
0 |
0 |
1
|
AVPR2
|
0 |
1
|
0 |
0 |
0 |
1
|
CACNA1E
|
1
|
0 |
0 |
0 |
0 |
1
|
CACNA1G
|
1
|
0 |
0 |
0 |
0 |
1
|
CEP290
|
1
|
0 |
0 |
0 |
0 |
1
|
CFTR, LOC111674475
|
1
|
0 |
0 |
0 |
0 |
1
|
CPLANE1
|
0 |
0 |
1
|
0 |
0 |
1
|
CPS1
|
0 |
1
|
0 |
0 |
0 |
1
|
CREBBP
|
0 |
0 |
0 |
1
|
0 |
1
|
CRLF1
|
0 |
1
|
0 |
0 |
0 |
1
|
CSNK2A1
|
1
|
0 |
0 |
0 |
0 |
1
|
DGUOK, LOC129934096
|
0 |
1
|
0 |
0 |
0 |
1
|
DPAGT1
|
0 |
1
|
0 |
0 |
0 |
1
|
DYRK1A
|
0 |
1
|
0 |
0 |
0 |
1
|
DYSF
|
0 |
1
|
0 |
0 |
0 |
1
|
ELANE
|
0 |
1
|
0 |
0 |
0 |
1
|
EVC2
|
1
|
0 |
0 |
0 |
0 |
1
|
F11
|
0 |
1
|
0 |
0 |
0 |
1
|
FBXL4
|
0 |
1
|
0 |
0 |
0 |
1
|
FGF12
|
0 |
1
|
0 |
0 |
0 |
1
|
FGFR3
|
1
|
0 |
0 |
0 |
0 |
1
|
GAREM2, HADHA
|
0 |
1
|
0 |
0 |
0 |
1
|
GPR143
|
0 |
1
|
0 |
0 |
0 |
1
|
HECW2
|
0 |
0 |
0 |
1
|
0 |
1
|
HMGCS2
|
1
|
0 |
0 |
0 |
0 |
1
|
IFT140, LOC105371046
|
0 |
0 |
1
|
0 |
0 |
1
|
IFT43
|
0 |
1
|
0 |
0 |
0 |
1
|
IMMT
|
0 |
0 |
1
|
0 |
0 |
1
|
KCNH2
|
1
|
0 |
0 |
0 |
0 |
1
|
KCNQ1, KCNQ1OT1
|
1
|
0 |
0 |
0 |
0 |
1
|
KCNQ2
|
1
|
0 |
0 |
0 |
0 |
1
|
KMT2D
|
1
|
0 |
0 |
0 |
0 |
1
|
LDLR
|
1
|
0 |
0 |
0 |
0 |
1
|
LHX3
|
0 |
1
|
0 |
0 |
0 |
1
|
LOC130002203, NANS, TRIM14
|
0 |
1
|
0 |
0 |
0 |
1
|
MMAB, MVK
|
1
|
0 |
0 |
0 |
0 |
1
|
MMACHC
|
1
|
0 |
0 |
0 |
0 |
1
|
MOCS2
|
1
|
0 |
0 |
0 |
0 |
1
|
MYH6
|
0 |
0 |
1
|
0 |
0 |
1
|
NBEA
|
0 |
0 |
0 |
1
|
0 |
1
|
NEB
|
0 |
0 |
1
|
0 |
0 |
1
|
NEK1
|
1
|
0 |
0 |
0 |
0 |
1
|
NR0B1
|
0 |
1
|
0 |
0 |
0 |
1
|
OTC
|
1
|
0 |
0 |
0 |
0 |
1
|
PEX7
|
1
|
0 |
0 |
0 |
0 |
1
|
PIGB
|
1
|
0 |
0 |
0 |
0 |
1
|
PNP
|
0 |
0 |
1
|
0 |
0 |
1
|
PRF1
|
0 |
1
|
0 |
0 |
0 |
1
|
PTPN11
|
1
|
0 |
0 |
0 |
0 |
1
|
RANBP2
|
0 |
1
|
0 |
0 |
0 |
1
|
SCN2A
|
0 |
1
|
0 |
0 |
0 |
1
|
SH3TC2
|
1
|
0 |
0 |
0 |
0 |
1
|
SLC25A12
|
0 |
1
|
0 |
0 |
0 |
1
|
SRD5A3
|
0 |
0 |
1
|
0 |
0 |
1
|
STXBP1
|
1
|
0 |
0 |
0 |
0 |
1
|
TMEM53
|
0 |
0 |
1
|
0 |
0 |
1
|
TMEM67
|
1
|
0 |
0 |
0 |
0 |
1
|
TRAPPC2L
|
0 |
0 |
1
|
0 |
0 |
1
|
TRRAP
|
0 |
0 |
0 |
1
|
0 |
1
|
UGP2
|
1
|
0 |
0 |
0 |
0 |
1
|
WNT7A
|
1
|
0 |
0 |
0 |
0 |
1
|
WWOX
|
1
|
0 |
0 |
0 |
0 |
1
|
Condition and significance breakdown #
Condition |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
total |
Propionic acidemia
|
26
|
0 |
0 |
0 |
2
|
28
|
Glycogen storage disease, type II
|
13
|
8
|
2
|
0 |
0 |
23
|
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
|
1
|
5
|
14
|
0 |
0 |
20
|
Maple syrup urine disease
|
20
|
0 |
0 |
0 |
0 |
20
|
Long QT syndrome 1
|
17
|
0 |
0 |
0 |
0 |
17
|
Fructose-biphosphatase deficiency
|
3
|
4
|
0 |
0 |
0 |
7
|
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
|
6
|
0 |
0 |
0 |
0 |
6
|
Osteogenesis imperfecta
|
2
|
4
|
0 |
0 |
0 |
6
|
Osteogenesis imperfecta, recessive perinatal lethal
|
2
|
4
|
0 |
0 |
0 |
6
|
X-linked agammaglobulinemia
|
6
|
0 |
0 |
0 |
0 |
6
|
Achondrogenesis type II
|
0 |
4
|
0 |
0 |
0 |
4
|
Cone-rod dystrophy 12
|
1
|
2
|
0 |
0 |
0 |
3
|
Cystic fibrosis
|
2
|
1
|
0 |
0 |
0 |
3
|
Methylmalonic aciduria, cblB type
|
3
|
0 |
0 |
0 |
0 |
3
|
Achondrogenesis, type IA
|
1
|
1
|
0 |
0 |
0 |
2
|
Achondrogenesis, type IB
|
2
|
0 |
0 |
0 |
0 |
2
|
Alkaptonuria
|
1
|
0 |
1
|
0 |
0 |
2
|
Atelosteogenesis type II
|
1
|
1
|
0 |
0 |
0 |
2
|
Bartter disease type 2
|
2
|
0 |
0 |
0 |
0 |
2
|
Congenital myasthenic syndrome 13
|
0 |
2
|
0 |
0 |
0 |
2
|
Cranioectodermal dysplasia 4
|
0 |
1
|
1
|
0 |
0 |
2
|
DPAGT1-congenital disorder of glycosylation
|
0 |
2
|
0 |
0 |
0 |
2
|
Desbuquois dysplasia 1
|
2
|
0 |
0 |
0 |
0 |
2
|
Hypotrichosis 14
|
0 |
0 |
2
|
0 |
0 |
2
|
Long QT syndrome 3
|
2
|
0 |
0 |
0 |
0 |
2
|
Marfan syndrome
|
2
|
0 |
0 |
0 |
0 |
2
|
Methylmalonic aciduria, cblA type
|
2
|
0 |
0 |
0 |
0 |
2
|
Microcephaly and chorioretinopathy 1
|
0 |
2
|
0 |
0 |
0 |
2
|
Niemann-Pick disease, type C1
|
0 |
1
|
1
|
0 |
0 |
2
|
Progressive sclerosing poliodystrophy
|
0 |
2
|
0 |
0 |
0 |
2
|
Pyridoxine-dependent epilepsy
|
0 |
2
|
0 |
0 |
0 |
2
|
Pyruvate dehydrogenase E3-binding protein deficiency
|
1
|
0 |
1
|
0 |
0 |
2
|
Short-rib thoracic dysplasia 19 with or without polydactyly
|
1
|
1
|
0 |
0 |
0 |
2
|
3-hydroxy-3-methylglutaryl-CoA synthase deficiency
|
1
|
0 |
0 |
0 |
0 |
1
|
Autosomal recessive limb-girdle muscular dystrophy type 2B
|
0 |
1
|
0 |
0 |
0 |
1
|
Charcot-Marie-Tooth disease type 4C
|
1
|
0 |
0 |
0 |
0 |
1
|
Cobalamin C disease
|
1
|
0 |
0 |
0 |
0 |
1
|
Congenital adrenal hypoplasia, X-linked
|
0 |
1
|
0 |
0 |
0 |
1
|
Congenital bile acid synthesis defect 2
|
0 |
0 |
1
|
0 |
0 |
1
|
Congenital hyperammonemia, type I
|
0 |
1
|
0 |
0 |
0 |
1
|
Craniotubular dysplasia, Ikegawa type
|
0 |
0 |
1
|
0 |
0 |
1
|
DYRK1A-related intellectual disability syndrome
|
0 |
1
|
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy 6B
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 11
|
0 |
1
|
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 28
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 39
|
0 |
1
|
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 4
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 47
|
0 |
1
|
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 69
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 7
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 80
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental and epileptic encephalopathy, 83
|
1
|
0 |
0 |
0 |
0 |
1
|
Developmental delay with or without dysmorphic facies and autism
|
0 |
0 |
0 |
1
|
0 |
1
|
Diastrophic dysplasia
|
0 |
1
|
0 |
0 |
0 |
1
|
Ellis-van Creveld syndrome
|
1
|
0 |
0 |
0 |
0 |
1
|
Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis
|
0 |
0 |
1
|
0 |
0 |
1
|
Familial acute necrotizing encephalopathy
|
0 |
1
|
0 |
0 |
0 |
1
|
Familial hemophagocytic lymphohistiocytosis 2
|
0 |
1
|
0 |
0 |
0 |
1
|
Hereditary factor XI deficiency disease
|
0 |
1
|
0 |
0 |
0 |
1
|
Hypercholesterolemia, familial, 1
|
1
|
0 |
0 |
0 |
0 |
1
|
Hypertrophic cardiomyopathy 14
|
0 |
0 |
1
|
0 |
0 |
1
|
Interstitial lung disease due to ABCA3 deficiency
|
0 |
1
|
0 |
0 |
0 |
1
|
Joubert syndrome 5
|
1
|
0 |
0 |
0 |
0 |
1
|
Kabuki syndrome 1
|
1
|
0 |
0 |
0 |
0 |
1
|
Lessel-Kreienkamp syndrome
|
0 |
0 |
0 |
1
|
0 |
1
|
Long QT syndrome 2
|
1
|
0 |
0 |
0 |
0 |
1
|
Meckel syndrome, type 3
|
1
|
0 |
0 |
0 |
0 |
1
|
Mitochondrial DNA depletion syndrome 13
|
0 |
1
|
0 |
0 |
0 |
1
|
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)
|
0 |
1
|
0 |
0 |
0 |
1
|
Mitochondrial trifunctional protein deficiency
|
0 |
1
|
0 |
0 |
0 |
1
|
Nemaline myopathy 2
|
0 |
0 |
1
|
0 |
0 |
1
|
Nephrogenic syndrome of inappropriate antidiuresis
|
0 |
1
|
0 |
0 |
0 |
1
|
Neurodevelopmental disorder with hypotonia, seizures, and absent language
|
0 |
0 |
0 |
1
|
0 |
1
|
Neurodevelopmental disorder with or without early-onset generalized epilepsy
|
0 |
0 |
0 |
1
|
0 |
1
|
Neutropenia, severe congenital, 1, autosomal dominant
|
0 |
1
|
0 |
0 |
0 |
1
|
Non-acquired combined pituitary hormone deficiency with spine abnormalities
|
0 |
1
|
0 |
0 |
0 |
1
|
Noonan syndrome 1
|
1
|
0 |
0 |
0 |
0 |
1
|
Nystagmus 6, congenital, X-linked
|
0 |
1
|
0 |
0 |
0 |
1
|
Okur-Chung neurodevelopmental syndrome
|
1
|
0 |
0 |
0 |
0 |
1
|
Ornithine carbamoyltransferase deficiency
|
1
|
0 |
0 |
0 |
0 |
1
|
Orofaciodigital syndrome type 6
|
0 |
0 |
1
|
0 |
0 |
1
|
Osteogenesis imperfecta with normal sclerae, dominant form
|
1
|
0 |
0 |
0 |
0 |
1
|
Purine-nucleoside phosphorylase deficiency
|
0 |
0 |
1
|
0 |
0 |
1
|
Rhizomelic chondrodysplasia punctata type 1
|
1
|
0 |
0 |
0 |
0 |
1
|
Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1
|
0 |
0 |
0 |
1
|
0 |
1
|
SRD5A3-congenital disorder of glycosylation
|
0 |
0 |
1
|
0 |
0 |
1
|
Saldino-Mainzer syndrome
|
0 |
0 |
1
|
0 |
0 |
1
|
Schinzel phocomelia syndrome
|
1
|
0 |
0 |
0 |
0 |
1
|
See cases
|
0 |
0 |
1
|
0 |
0 |
1
|
Severe myoclonic epilepsy in infancy
|
1
|
0 |
0 |
0 |
0 |
1
|
Short-rib thoracic dysplasia 18 with polydactyly
|
0 |
1
|
0 |
0 |
0 |
1
|
Short-rib thoracic dysplasia 6 with or without polydactyly
|
1
|
0 |
0 |
0 |
0 |
1
|
Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
|
1
|
0 |
0 |
0 |
0 |
1
|
Spondyloepimetaphyseal dysplasia, Genevieve type
|
0 |
1
|
0 |
0 |
0 |
1
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B
|
1
|
0 |
0 |
0 |
0 |
1
|
Thanatophoric dysplasia type 1
|
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.